Apoptosis in rheumatoid arthritis

Current Opinion in Rheumatology

Volumn 15, Issue 3, 2003, Pages 274-279

  Baier, Anja ^a   Meineckel, Ingmar ^a   Gay, Steffen ^b   Pap, Thomas ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Center of Experimental Rheumatology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 8; CD4 ANTIGEN; DNA BINDING PROTEIN; DNA FRAGMENT; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN P53; PROTEOGLYCAN; RNA; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; SUMO 1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; CARCINOGENESIS; CHEMOTHERAPY; CLONAL ANERGY; COCULTURE; DNA DAMAGE; FIBROBLAST; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ULTRAVIOLET RADIATION; X RAY;

ANTIRHEUMATIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ARTHRITIS, RHEUMATOID; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELLS, CULTURED; FEMALE; FIBROBLASTS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PRIMARY PREVENTION; PROGNOSIS; PROTEINS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE;

EID: 0038070180     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200305000-00015     Document Type: Review

References (55)

1. Pap T, Gay RE, Gay S: Rheumatoid arthritis. In The molecular pathology of autoimmune diseases, edn 2. Edited by Theofilopoulos AN, Bona CA. New York: Taylor & Francis; 2002:376-401.
2. Fadok VA, Bratton DL, Konowal A, et al.: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998, 101:890-898.
3. Fadok VA, Bratton DL, Rose DM, et al.: A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000, 405:85-90.
4. Haynes BF, Grover BJ, Whichard LP, et al.: Synovial microenvironment-T cell interactions: human T cells bind to fibroblast-like synovial cells in vitro. Arthritis Rheum 1988, 31:947-955.
5. Ali M, Ponchel F, Wilson KE, et al.: Rheumatoid arthritis synovial T cells regulate transcription of several genes associated with antigen-induced anergy. J Clin Invest 2001, 107:519-528. The authors identify transcriptional changes that are associated with T cell anergy in RA synovial T cells. Specifically, they provide a link between the downregulation of calmodulin and impaired T cell responsiveness in RA. This interesting paper supports the concept of T cell anergy in the rheumatoid synovium.
6. Yamamura Y, Gupta R, Morita Y, et al.: Effector function of resting T cells: activation of synovial fibroblasts. J Immunol 2001, 166:2270-2275. This paper demonstrates the upregulation of cytokines and MMPs in RA-SF by resting T cells. The findings demonstrate that resting T cells in the absence of specific antigen stimulation may contribute to the activation of synovial fibroblasts in conditions, in which large numbers of T cells are in direct contact with these cells.
7. Firestein GS, Yeo M, Zvaifler NJ: Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995, 96:1631-1638.
8. Schirmer M, Vallejo AN, Weyand CM, et al.: Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients. J Immunol 1998, 161:1018-1025.
9. Zhang J, Bardos T, Mikecz K, et al.: Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis. J Immunol 2001, 166:4981-4986.
10. Salmon M, Scheel Toellner D, Huissoon AP, et al.: Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 1997, 99:439-446.
11. Nanki T, Hayashida K, El Gabalawy HS, et al.: Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol 2000, 165:6590-6598.
12. Suzuki Y, Rahman M, Mitsuya H: Diverse transcriptional response of CD4(+) T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4(+) T cells. J Immunol 2001, 167:3064-3073. The authors provide strong evidence that SDF-1, as produced by fibroblast-like cells, modulates the behavior of T cells. Consequently, this paper strengthens the concept that RA-SF may contribute significantly to T cell accumulation in the rheumatoid synovium.
13. Lindhout E, van Eijk M, van Pel M, et al.: Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. J Immunol 1999, 162:5949-5956.
14. Hayashida K, Shimaoka Y, Ochi T, et al.: Rheumatoid arthritis synovial stromal cells inhibit apoptosis and up-regulate Bcl-xL expression by B cells in a CD49/CD29-CD106-dependent mechanism. J Immunol 2000, 164:1110-1116.
15. Reparon-Schuijt CC, van Esch WJ, van Kooten C, et al.: Regulation of synovial B cell survival in rheumatoid arthritis by vascular cell adhesion molecule 1 (CD106) expressed on fibroblast-like synoviocytes. Arthritis Rheum 2000, 43:1115-1121.
16. Pap T, Müller-Ladner U, Gay RE, et al.: Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2000, 2:361-367.
17. Perlman H, Liu H, Georganas C, et al.: Differential expression pattern of the antiapoptotic proteins, Bcl-2 and FLIP, in experimental arthritis. Arthritis Rheum 2001, 44:2899-2908.
18. Li P, Nijhawan D, Budihardjo I, et al.: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489.
19. Marsden VS, O'Connor L, O'Reilly LA, et al.: Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 2002, 419:634-637. The data are not related directly to arthritis, but the demonstration that Bcl-2 regulates a caspase activation program independently of the cytochrome c/Apaf-1/caspase-9 complex is of fundamental importance and may affect apoptosis research in RA, where Bcl-2 has been found to be upregulated in a variety of synovial cells.
20. Matsumoto S, Muller Ladner U, Gay RE, et al.: Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 1996, 23:1345-1352.
21. Perlman H, Georganas C, Pagliari LJ, et al.: Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol 2000, 164:5227-5235.
22. Kurowska M, Rudnicka W, Kontny E, et al.: Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2. J Immunol 2002, 169:1760-1767. This paper shows that autocrine stimulation of RA-SF with IL-15 results in the overexpression of antiapoptotic members of the Bcl-family and contributes to the resistance of RA-SF to apoptosis. The data provide another important link between stable activation of RA-SF and the cytokine network.
23. Itoh N, Nagata S: A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 1993, 268:10932-10937.
24. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
25. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998, 281:1312-1316.
26. Hasunuma T, Kayagaki N, Asahara H, et al.: Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 1997, 40:80-86.
27. Irmler M, Thome M, Hahne M, et al.: Inhibition of death receptor signals by cellular FLIP. Nature 1997, 388:190-195.
28. Perlman H, Pagliari LJ, Liu H, et al.: Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum 2001, 44:21-30. These data provide evidence that the resistance of RA macrophages is related closely to the expression of FLIP
29. Schedel J, Gay RE, Kuenzler P, et al.: FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis. Arthritis Rheum 2002, 46:1512-1518. The paper extends the data on the role of FLIP in RA by demonstrating a prominent expression of FLIP in RA-SF that are involved directly in the destruction of articular cartilage and bone.
30. Catrina AI, Ulfgren AK, Lindblad S, et al.: Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium. Ann Rheum Dis 2002, 61:934-936.
31. Okura T, Gong L, Kamitani T, et al.: Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol 1996, 157:4277-4281.
32. Gostissa M, Hengstermann A, Fogal V, et al.: Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 1999, 18:6462-6471.
33. Muller S, Berger M, Lehembre F, et al.: c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 2000, 275:13321-13329.
34. Rodriguez MS, Desterro JM, Lain S, et al.: SUMO-1 modification activates the transcriptional response of p53. EMBO J 1999, 18:6455-6461.
35. Desterro JM, Rodriguez MS, Hay RT: SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 1998, 2:233-239.
36. Matunis MJ, Coutavas E, Blobel G: A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 1996, 135:1457-1470.
37. Muller S, Matunis MJ, Dejean A: Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 1998, 17:61-70.
38. Franz JK, Pap T, Hummel KM, et al.: Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum 2000, 43:599-607.
39. κB in the regulation of cell death and survival.
40. Aupperle KR, Bennett BL, Boyle DL, et al.: NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes. J Immunol 1999, 163:427-433.
41. Georganas C, Liu H, Perlman H, et al.: Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c- Jun. J Immunol 2000, 165:7199-7206.
42. Li P, Sanz I, O'Keefe RJ, et al.: NF-kappa B regulates VCAM-1 expression on fibroblast-like synoviocytes. J Immunol 2000, 164:5990-5997.
43. Vincenti MP, Coon CI, Brinckerhoff CE: Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts. Arthritis Rheum 1998, 41:1987-1994.
44. Miagkov AV, Kovalenko DV, Brown CE, et al.: NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA 1998, 95:13859-13864.
45. Makarov SS: NF-κB in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res 2001, 3:200-206.
46. Beraud C, Henzel WJ, Baeuerle PA: Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc Natl Acad Sci USA 1999, 96:429-434.
47. Ozes ON, Mayo LD, Gustin JA, et al.: NF-kappaB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 1999, 401:82-85.
48. Zhang HG, Wang Y, Xie JF, et al.: Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum 2001, 44:1555-1567. The data are important because they demonstrate that, unlike in osteoarthritis synovial fibroblasts, the protein kinase Akt may act as a survival signal in RA-SF. Moreover, downstream signaling molecules such as Akt are suggested to be key regulators of the apoptotic response to TNF-α in RA-SF.
49. Kim G, Jun JB, Elkon KB: Necessary role of phosphatidylinositol 3-kinase in transforming growth factor beta-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2002, 46:1504-1511.
50. Shouda T, Yoshida T, Hanada T, et al.: Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 2001, 108:1781-1788.
51. Krause A, Scaletta N, Ji JD, et al.: Rheumatoid arthritis synoviocyte survival is dependent on stat3. J Immunol 2002, 169:6610-6616.
52. Firestein GS, Echeverri F, Yeo M, et al.: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 1997, 94:10895-10900.
53. Tak PP, Smeets TJ, Boyle DL, et al.: p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis. Arthritis Rheum 1999, 42:948-953.
54. Yamanishi Y, Boyle DL, Rosengren S, et al.: Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 2002, 99:10025-10030. In this study, microdissected synovial tissues from RA patients were analyzed for the presence and distribution of p53 mutations. Abundant p53 transition mutations were found in clustered areas together with increased expression of IL-6. These data appear to confirm previous observations on the presence of p53 mutations in RA and link these to the oligoclonal expansion of RA-SF as well as increased cytokine production.
55. Pap T, Aupperle KR, Gay S, Firestein GS, et al.: Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis Rheum 2001, 44:676-681.